COSM
Cosmos Health Inc
$
0.848
- Overview
- Forecast
- Valuation
- Earnings
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
0.920
Open
0.8965
VWAP
0.88
Vol
370.22K
Mkt Cap
24.38M
Low
0.848
Amount
327.08K
EV/EBITDA(TTM)
--
Total Shares
16.85M
EV
38.68M
EV/OCF(TTM)
--
P/S(TTM)
0.37
Cosmos Health Inc. is a diversified, vertically integrated global healthcare company. The Company owns a portfolio of proprietary pharmaceutical and nutraceutical brands, including Sky Premium Life, Mediterranation, bio-bebe, C-Sept and C-Scrub. Through its subsidiary Cana Laboratories S.A., it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. It also distributes a broad line of pharmaceuticals and parapharmaceuticals, including branded generics and over-the-counter (OTC) medications, to retail pharmacies and wholesale distributors through its subsidiaries in Greece and the United Kingdom. It also has research and development (R&D) partnerships targeting health disorders such as obesity, diabetes, and cancer, enhanced by artificial intelligence drug repurposing technologies, and focuses on the R&D of patented nutraceuticals, specialized root extracts, proprietary complex generics, and OTC products.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q1
FY2024Q4
15.50M
+6.28%
--
--
14.50M
-8.46%
--
--
Estimates Revision
The market is revising No Change the revenue expectations for Cosmos Health Inc. (COSM) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by 97.69%.
Revenue Estimates for FY2025
No Change
0.00%
In Past 3 Month
Stock Price
Go Up
+97.69%
In Past 3 Month
1 Analyst Rating
Wall Street analysts forecast COSM stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for COSM is 1.00 USD with a low forecast of 1.00 USD and a high forecast of 1.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Buy
1 Hold
0 Sell
Hold
Current: 0.848
Low
1.00
Averages
1.00
High
1.00
Current: 0.848
Low
1.00
Averages
1.00
High
1.00
The End
See All Ratings
No Data
Valuation Metrics
The current forward P/E ratio for Cosmos Health Inc (COSM.O) is 89.53, compared to its 5-year average forward P/E of 1.86. For a more detailed relative valuation and DCF analysis to assess Cosmos Health Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
N/A
5Y Average PE
1.86
Current PE
89.53
Overvalued PE
16.34
Undervalued PE
-12.63
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
N/A
5Y Average EV/EBITDA
-2.38
Current EV/EBITDA
10.82
Overvalued EV/EBITDA
6.31
Undervalued EV/EBITDA
-11.08
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
N/A
5Y Average PS
0.19
Current PS
0.38
Overvalued PS
0.44
Undervalued PS
-0.06
Financials
Annual
Quarterly
FY2025Q2
YoY :
+11.65%
14.75M
Total Revenue
FY2025Q2
YoY :
+5.73%
-2.65M
Operating Profit
FY2025Q2
YoY :
+9.16%
-2.83M
Net Income after Tax
FY2025Q2
YoY :
-33.33%
-0.10
EPS - Diluted
FY2025Q2
YoY :
+6.70%
-1.33M
Free Cash Flow
FY2025Q2
YoY :
+59.59%
5.49
Gross Profit Margin - %
FY2025Q2
YoY :
-52.10%
-10.48
FCF Margin - %
FY2025Q2
YoY :
-2.24%
-19.18
Net Margin - %
FY2025Q2
N/A
ROIC
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
12
896.0K
USD
Months
6-9
10
739.0K
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
12
896.0K
USD
Months
6-9
10
739.0K
USD
Months
0-12
0
0.0
USD
Months
COSM News & Events
Events Timeline
2025-08-12 (ET)
2025-08-12
09:54:35
Cosmos makes initial $1M ethereum purchase under digital asset treasury strategy
2025-08-06 (ET)
2025-08-06
09:22:46
Cosmos Health secures $300M financing facility to launch Ethereum strategy
2025-06-24 (ET)
2025-06-24
10:59:17
Cosmos Health enters U.S. market with DolCas Biotech agreement
Sign Up For More Events
Sign Up For More Events
News
8.5
08-12NewsfilterCosmos Health Makes Initial $1M Ethereum Purchase Under Digital Asset Treasury Strategy
8.5
08-07BenzingaEthereum Treasury Strategy Fuels Cosmos Health's $300 Million Financing Deal—Stock Surges 31%
8.5
08-06NASDAQ.COMCosmos Health Secures $300 Mln To Launch Ethereum Treasury Strategy
Sign Up For More News
People Also Watch
XTIA
XTI Aerospace Inc
1.820
USD
+2.82%
NRXS
Neuraxis Inc
2.480
USD
+2.90%
COEP
Coeptis Therapeutics Holdings Inc
14.655
USD
+4.90%
DUO
Fangdd Network Group Ltd
1.520
USD
+0.66%
NXTT
Next Technology Holding Inc
1.120
USD
-1.75%
WETH
Wetouch Technology Inc
0.864
USD
-2.92%
BOLT
Bolt Biotherapeutics Inc
5.070
USD
-1.55%
COHN
Cohen & Company Inc
12.700
USD
+0.87%
MEIP
MEI Pharma Inc
4.880
USD
-0.20%
FAQ
What is Cosmos Health Inc (COSM) stock price today?
The current price of COSM is 0.8481 USD — it has decreased -5.25 % in the last trading day.
What is Cosmos Health Inc (COSM)'s business?
What is the price predicton of COSM Stock?
What is Cosmos Health Inc (COSM)'s revenue for the last quarter?
What is Cosmos Health Inc (COSM)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for Cosmos Health Inc (COSM)'s fundamentals?
How many employees does Cosmos Health Inc (COSM). have?